Blood Transfusions and Immune Response

NACompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Infection After TransfusionTransfusion-related Immunomodulation ReactionCytokine StormSurgery
Interventions
PROCEDURE

restrictive transfusion strategy

Patients allocated to the restrictive transfusion strategy were transfused only when their hemoglobin concentration decreased below 7.7 g d dL-1 and were then maintained at hemoglobin concentrations between 7.7 and 9.9 g d dL-1.

PROCEDURE

liberal transfusion strategy

Patients assigned to the liberal strategy were transfused when their hemoglobin concentration fell below 9.9 g dL-1, aiming at maintaining hemoglobin at or above 10 g dL-1.

Trial Locations (1)

115 28

Aretaieion University Hospital, Athens

All Listed Sponsors
lead

Aretaieion University Hospital

OTHER

NCT02020525 - Blood Transfusions and Immune Response | Biotech Hunter | Biotech Hunter